Nour Abdallah (@nourabdalllah) 's Twitter Profile
Nour Abdallah

@nourabdalllah

Internal Medicine Resident @UConnIM | Research Fellow @ClevelandClinic | Medical Doctor🇱🇧🇺🇸

ID: 1442604594245222411

calendar_today27-09-2021 21:38:43

225 Tweet

586 Followers

459 Following

Nour Abdallah (@nourabdalllah) 's Twitter Profile Photo

Wrapping up #AUA24 in San Antonio! I had a blast presenting our work on IsoPSA use in prostate cancer and artificial intelligence in kidney cancer. All thanks to Chris Weight Cleveland Clinic Urology

Wrapping up #AUA24 in San Antonio! I had a blast presenting our work on IsoPSA use in prostate cancer and artificial intelligence in kidney cancer. All thanks to <a href="/cjweight/">Chris Weight</a> <a href="/CleClinicUro/">Cleveland Clinic Urology</a>
Cleveland Clinic Urology (@cleclinicuro) 's Twitter Profile Photo

Sharing the bittersweet news that Georges-Pascal Haber, MD, PhD, will be departing as Chair of Urology. Dr. Haber has been appointed CEO of Cleveland Clinic Abu Dhabi, effective June 1st. We thank him for leading our GUKI family over the years & wish him nothing but the best!

Sharing the bittersweet news that Georges-Pascal Haber, MD, PhD, will be departing as Chair of Urology. Dr. Haber has been appointed CEO of Cleveland Clinic Abu Dhabi, effective June 1st. We thank him for leading our GUKI family over the years &amp; wish him nothing but the best!
Christian Mouchati (@chrismouchati) 's Twitter Profile Photo

Wrapping up #SLEEP2024, we shared Nancy Foldvary-Schaefer, DO, MS work on 32h PSG to Dx Idiopathic Hypersomnia, Antidepressants effect on REM sleep without atonia, and an RCT evaluating the use of Computerized CBTi compared to controls on sleep hygiene in epilepsy patients! Cleveland Clinic

Wrapping up #SLEEP2024, we shared <a href="/NancyFoldvaryDO/">Nancy Foldvary-Schaefer, DO, MS</a> work on 32h PSG to Dx Idiopathic Hypersomnia, Antidepressants effect on REM sleep without atonia, and an RCT evaluating the use of Computerized CBTi compared to controls on sleep hygiene in epilepsy patients! <a href="/ClevelandClinic/">Cleveland Clinic</a>
OncoDaily (@oncodaily) 's Twitter Profile Photo

ASCO24 Updates: Exploring the Role of ACP1: Molecular Insights and Clinical Impact ASCO Nour Abdallah Cleveland Clinic oncodaily.com/dialogues/7966… #ASCO24 #ASCO #Cancer #ProstateCancer #OncoDaily #OncoDaily

Nour Abdallah (@nourabdalllah) 's Twitter Profile Photo

ACP1-High tumors have a distinct molecular profile, which highlights ACP1’s potential role in pathogenesis and therapeutic targeting. Huge thanks to Rana McKay, MD, FASCO for leading this project to publication! ascopubs.org/doi/10.1200/PO…

Rana McKay, MD, FASCO (@drranamckay) 's Twitter Profile Photo

So proud of ⁦Nour Abdallah⁩ for leading this work in ⁦JCO Precision Oncology⁩ evaluating ACP1 expression in PCa. We show enrichment in distant mets, increased TP53 alternations and cold TME. ⁦⁦Toni Choueiri, MD⁩ ⁦OncoDaily⁩ ⁦Sumanta K. Pal, MD, FASCO⁩ ascopubs.org/doi/10.1200/PO…

Christian Mouchati (@chrismouchati) 's Twitter Profile Photo

Check out our newest article with Atiwat Soontornpun @AtiwatMD led by Nancy Foldvary-Schaefer, DO, MS. Adults with epilepsy having a PSG-confirmed moderate/severe OSA had higher rSUDEP-7 scores, potentially increasing their risk for Sudden Unexpected Death in Epilepsy Cleveland Clinic pubmed.ncbi.nlm.nih.gov/39488098/

OncoDaily (@oncodaily) 's Twitter Profile Photo

Evaluating ACP1 expression in prostrate cancer - Rana McKay, MD, FASCO Nour Abdallah JCO Precision Oncology oncodaily.com/insight/rana-m… #Cancer #JCO #PrecisionOncology #OncoDaily #Oncology #MedEd #MedX #MedNews #Medicine

Nour Abdallah (@nourabdalllah) 's Twitter Profile Photo

Learn how AI can change how we diagnose kidney cancer! Check out our latest chapter on this exciting tech in healthcare. Rebecca Campbell Nicholas Heller Chris Weight Cleveland Clinic Urology Kidney cancer diagnostics using AI and radiomics sciencedirect.com/science/articl… #KidneyCancer #AI #Radiomics

Chris Weight (@cjweight) 's Twitter Profile Photo

IsoPSA is associated with low risk (4.3%) of clin sig prostate cancer for 2 years after a single test! This suggests that patients and physicians can feel fairly confident that a biopsy is not necessary if the IsoPSA is low Nour Abdallah 👏👏 url.us.m.mimecastprotect.com/s/0TmdCG6xpNtA…